Establishes immunity for businesses against damage claims for COVID-19 exposure; excludes reckless or intentional conduct.
Impact
If passed, this law will significantly impact the way businesses handle potential exposure claims arising from COVID-19, effectively providing a protective shield against lawsuits filed by patrons or employees due to virus-related incidents. The immunity extends to a wide array of businesses, including individual proprietors and corporate entities. However, it is crucial to note that immunity does not apply in cases of willful misconduct, reckless infliction of harm, or intentional infliction of harm, leaving room for accountability in severe cases of negligence.
Summary
Senate Bill 110, known as the 'New Jersey COVID-19 related Business Immunity Act', aims to provide businesses with immunity from civil liability concerning claims for damages arising from individual exposure to COVID-19 on their premises. The intent of the bill is to support the economic recovery of businesses that faced numerous challenges during the pandemic by encouraging them to operate without the fear of litigation related to COVID-19 exposure. This immunity applies to damages or injuries occurring on business premises or during activities managed by the business.
Contention
The bill has sparked debate among legislators, advocates, and business owners. Proponents argue that removing the risk of costly litigation will allow businesses to thrive as they recover from the economic downturn triggered by COVID-19. Critics, however, express concerns that such immunity could lead to lax safety practices as businesses may neglect the implementation of adequate health guidelines, believing they are shielded from legal repercussions. There is apprehension that the bill could undermine public health interests at a time when vigilant protocols are still needed to mitigate virus transmission.